Tetraphase Pharmaceuticals to Present at Upcoming Investor Conferences
- Rodman & Renshaw 19th Annual
Global Investment Conferenceon Monday, September 11th, 2017 at 12:30 p.m. Eastern Timeat the Lotte New York Palace Hotelin New York City
Cantor Fitzgerald Global Healthcare Conferenceon Monday, September 25th at 1:50 p.m. Eastern Timeat the InterContinental New York Barclay Hotelin New York City
Live audio webcasts of the presentations will be available on the company's website at http://ir.tphase.com/events.cfm. Archived presentations will be available for 30 days.
About Tetraphase Pharmaceuticals, Inc.
Tetraphase is a clinical-stage biopharmaceutical company using its proprietary chemistry technology to create novel antibiotics for serious and life-threatening bacterial infections, including those caused by many of the multidrug-resistant (MDR) bacteria highlighted as urgent public health threats by the
Tetraphase Pharmaceuticals Teri Dahlman617-600-7040 firstname.lastname@example.org Argot Partners Maeve Conneighton206-899-4940 email@example.com Media Contact: Sam Brown Inc. Mike Beyer312-961-2502 firstname.lastname@example.org
News Provided by Acquire Media